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IN SEVERAL CHRONIC pathological conditions ranging from hypertension and excess pulmonary ventilation to bladder-obstructive disorders, mechanical strain plays a major role in triggering a pathological hypertrophy/ hyperplasia and abnormal extracellular matrix deposition, especially in the muscle compartments (6, 40, 48) . Those changes lead ultimately to important clinical consequences, including physiological insufficiencies and organ failure. Whereas the deleterious effects of chronic mechanical stresses are well established, the molecular mechanisms by which the mechanical stimulation affects cell function are still poorly understood.
Investigating the effect(s) of mechanical forces has been made possible by culturing cells on artificial flexible substrates (e.g., an elastic membrane) and applying defined, stepwise, or cyclic strain to the substrate, thus imparting approximately the same strain to the cells (28, 47) . With the use of cultured smooth muscle cells and well-defined in vitro mechanical devices, we and others (7, 12, 29) have shown that mechanical forces modulate cell shape, growth, and synthetic phenotype. These changes are achieved mainly through the activation of specific transducing pathways and reprogramming of gene expression. For instance, mechanical stimulation of muscle cells changes skeletal fibers from fast to slow or slow to fast types, which involves turning entire sets of muscle-specific genes on or off (38) . However, the full repertoire of strain-inducible genes is incompletely defined, and the biological significance of specific gene alterations is, as yet, an unresolved issue.
Cyr61, a cysteine-rich and heparin-binding protein, belongs to the CCN family [cysteine-rich 61/connective tissue growth factor (CTGF)/nephroblastoma overexpressed] (reviewed in Ref. 26 ). This emerging new family of proteins is characterized by a high degree of amino acid sequence homology and includes Cyr61, CTGF, Nov (nephroblastoma overexpressed), elm-1, cop-1, and wisp-3. These proteins are organized into conserved modular domains that share similarities with insulin-like growth factor binding proteins, von Willebrand factor type C repeat, thrombospondin type I repeat, and growth factor cysteine knots. In addition, each of these proteins possesses an amino-terminal signal peptide, indicating that they are secreted proteins. Their overall functions are thought to be the result of either combinatorial or independent actions of their domains.
Cyr61 and CTGF, the most extensively studied members of this family, were originally identified in 3T3 fibroblasts and human umbilical vein endothelial cells, respectively, by virtue of their transcriptional activation by serum and serum growth factors such as basic fibroblast growth factor, platelet-derived growth factor (PDGF), and transforming growth factor-␤ (2, 21, 23, 34) . Studies of their pattern of expression in vivo implicated these proteins in the development of fibrosis and vascular diseases (2, 26) . At the molecular level, the Cyr61 recombinant protein was able to support adhesion, migration, and mitogenesis of human skin fibroblasts through integrins ␣ 6 ␤ 1 , ␣ v ␤ 5 , and ␣ v ␤ 3 , respectively (10, 14) . Cyr61 also upregulates the expres-sion of matrix metalloproteinases 1 and 3 and promotes biological processes such as wound healing, angiogenesis, homeostasis, and thrombosis (14, 36) . Stable transfection of Cyr61 cDNA in MCF7 cells enhanced anchorage-independent cell growth in soft agar and significantly increased their tumorigenicity when tested in a nude mouse model, suggesting that Cyr61 promotes tumor growth (49) . The fact that Cyr61 affects a broad spectrum of biological activities in a celland context-specific manner prompts us to explore its potential regulation by mechanical forces in smooth muscle cells and examine the underlying molecular mechanisms involved in this process.
MATERIALS AND METHODS
Reagents. Chemical inhibitors were purchased from Calbiochem (San Diego, CA). All other chemicals used were of reagent grade. Y-27632 was kindly provided by Dr. T. Kondo and A. Yoshimura (Welfide, Osaka, Japan).
Cell culture and stretching. Primary cultures of smooth muscle cells were established from fetal bovine bladders as previously described (3) . Primary cultures from several animals were used in our experiments. Cells were maintained in modified medium 199 supplemented with 10% fetal bovine serum and antibiotics in a humidified atmosphere containing 5% CO 2 in air at 37°C. Freshly isolated smooth muscle cells were phenotypically characterized using muscle-specific antibodies against smooth muscle actin. These cells maintain several differentiated properties in culture even after several passages. Cells between their third and tenth population doubling level were used for stretch experiments.
Mechanical stretch of the cells was performed using a device designed to apply precise and reproducible biaxial strain to type I collagen-coated Tecoflex membrane (Thermedics) on which the cells were grown. Design, calibration, and description of the equibiaxial strain system for cultured cells have been previously reported (7, 47) . Typical experiments were carried out with 13 control and 13 experimental wells in which the cells were seeded at a density of 250,000 cells/well and incubated for 24 h in serum-containing medium. The medium was then removed and replaced by serum-free medium. For experimental wells, biaxial strain (0-10%) was applied by stretching the elastic membrane of the wells cyclically at a frequency of 0.3 Hz. For controls, cells were cultured in the apparatus wells under the same conditions but were not subjected to mechanical strain. After completion of the stretch regimen, control and stretched cells were pooled, divided into two samples, and processed for either RNA or protein analysis. Stretch and control apparatus wells were seeded using the same pool of cells, and analyses were carried out simultaneously and identically.
Drug treatments. Cells were plated in collagen-coated wells in serum-containing medium as described above. Twentyfour hours later, the medium was replaced with serum-free medium containing drugs as indicated in the text. The cells were left in the presence of a given inhibitor at least 30 min before the application of mechanical stretch for an additional 30 min. Stock solutions of each drug were made in either aqueous solution or in DMSO and diluted to a working concentration in serum-free medium.
Cyr61 cDNA probe and antibodies. An 886-bp cDNA fragment was amplified by PCR using total RNA from serumstimulated smooth muscle cells as a template together with the primer combinations 5ЈCCAGCTTGTTGGCGTCTT3Ј and 5ЈTTACATTTCCCCTCCCTCCC3Ј (32) . The PCR product was purified, cloned into the expression vector pCRII from Invitrogen, sequenced, and used in Northern blot analysis as a probe. Two 16-amino acid peptides (residues between 102 and 118 and 217 and 233 in the primary sequence of the human Cyr6, GenBank accession no. AF307860) were synthesized and purified by high-performance liquid chromatography (Biosynthesis). Each peptide was coupled to maleimide-activated KLH (Pierce) at a ratio of 1 mg of peptide per milligram of KLH. Antibodies were raised in rabbits by Cocalico Biologicals (Reamstown, PA). After completion of the immunization process, the rabbits were exsanguinated, and the antibodies were purified by affinity chromatography using affinity columns from Pharmacia. Bound antibodies were eluted with 100 mM glycine and immediately neutralized with Tris base and adjusted to a concentration of 0.4 mg/ml before storage at Ϫ20°C. Serum titer was determined by enzyme-linked immunosorbent assay.
Northern blot hybridization. Total RNA was extracted from cells as previously described (13) . A sample containing 12 g of total RNA was fractionated by electrophoresis in 1% agarose/formaldehyde gel, transferred to Zeta-Probe nylon filters (Bio-Rad, Richmond, CA), and hybridized to Cyr61-radiolabeled cDNA probe. A specific probe for CTGF was radiolabeled as well and hybridized to the filters that were stripped according the manufacturer's instructions (BioRad). Total RNA loading and transfer were evaluated by probing with a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probe. The filters were analyzed by phosphorimaging, and hybridization signals were quantified to determine the relative amounts of mRNA (Molecular Dynamics). The mRNA levels were analyzed in duplicate samples and normalized to equivalent values for GAPDH to compensate for loading and transfer.
Immunohistochemistry and immunoblotting. For Western blot analysis, lysates from stretched and control unstretched cells were prepared by harvesting the cells in 0.1% Triton X-100 lysis buffer as previously described (8) . Protein concentration was determined by using the Bradford protein assay (Bio-Rad). Protein samples (30 g) were separated by 10% SDS-polyacrylamide gel, transferred to nitrocellulose membrane, and Western blot analysis was performed using Cyr61 antibody. Immunodetection was performed using enhanced chemiluminescence (Amersham).
For immunohistochemistry analysis, cells were fixed with 3.7% formaldehyde in PBS and permeabilized with 0.5% Triton X-100 to allow the antibody binding to both extra-and intracellular antigen. Cells were incubated for 24 h with a 1:200 dilution of anti-Cyr61 antibody. Cells were then washed with PBS, and the immunodetection was then performed with a goat anti-rabbit IgG-rhodamine conjugate (1: 300 dilution). After a final wash, the membrane was mounted on a glass microscope slide, and the immunostaining was visualized by confocal microscopy.
Nuclear protein extraction. Cells were trypsinized, pelleted by centrifugation, and resuspended in ice-cold sucrose buffer containing 0.1% Triton X-100 to lyse the cells (5). When lysis was complete, the preparations were washed several times with lysis buffer to remove the cytoplasm and debris. The purity of nuclei preparations was verified by microscopic examination. These purified nuclear fractions were further extracted and subjected to Western blot analysis as described above.
for various periods of time. The magnitude and the strain rate used were previously shown to induce changes in growth and synthetic phenotype of these cells (4, 9) . Cells cultured under the same conditions but not subjected to mechanical strain were used as controls. Northern blot analysis of RNA (a representative experiment of which is shown in Fig. 1A ) demonstrates that Cyr61 mRNA was rapidly but transiently induced in stretched cells. Cyr61 mRNA levels peaked after 1 h of stretching and decayed to undetectable levels thereafter. Mechanical stretch of 1-h duration resulted in a five-to ninefold increase of Cyr61 mRNA, as determined by phosphorimager scanning of the hybridization signals (Fig. 1B) . In contrast, the application of mechanical stretch decreased the CTGF mRNA levels. However, this decrease was also seen in control cells cultured under static conditions for the same period of time, indicating lack of the proper effect of mechanical stretch on CTGF gene expression (data not shown). Furthermore, we examined the effects of strain magnitude by applying strains of 1.5, 2.5, 5, or 7.5% to the cells for 30 min and assessing the mRNA levels of Cyr61 and CTGF. As shown in Fig. 1C , mechanical stretch-induced Cyr61 gene expression was positively correlated with the magnitude of the mechanical strain. The minimal strain required to trigger this response was 2.5%. The CTGF mRNA levels were decreased in stretched cells to nearly the same extent regardless of the strain magnitude used.
To determine whether stretch-induced changes in Cyr61 mRNAs caused corresponding changes in protein levels, we performed Western blot analyses using specific monoclonal antibodies raised against selected immunogenic peptides of Cyr61. The polyclonal antibody reacted well with the bovine protein extract and recognized an ϳ42-kDa protein band in both stretched and control cell lysates ( Fig. 2A) . The application of mechanical stretch induced a nearly 3.5-fold increase of Cyr61 band intensity after 1 or 2 h of stretching, as determined by densitometric measurements (Fig. 2B) . Analyses of conditioned medium from stretched cells failed to detect Cyr61 protein in the supernatant (data not shown). Fig. 1 . Effect of cyclic mechanical stretch on Cyr61 mRNA levels in bladder smooth muscle cells. A: bladder smooth muscle cells were subjected to mechanical stretch (5% strain, 0.3 Hz) for the indicated time periods. Total RNA was prepared from the cells and subjected to Northern blot analysis using a specific DNA probe for Cyr61 as described in MATERIALS AND METHODS. For comparison, blots were stripped and reprobed for connective tissue growth factor (CTGF) mRNA. To control for equal RNA loading, the blot was hybridized with a specific glyceraldehyde-3-phosphate dehydrogenase (GAPDH) DNA probe. B: graphical representation of the results of phosphorimage scans of the hybridization signals. The values are normalized to those of the GAPDH signals and represent means Ϯ SE (n ϭ 4). C: cells were subjected to different strain magnitudes for 30 min, and the mRNAs for Cyr61 and CTGF were analyzed by Northern blot as described above. The cellular localization and distribution of the Cyr61 protein was examined by immunohistochemistry in stretched (5% strain, 1 h) and control nonstretched cells as described in MATERIALS AND METHODS. As shown in Fig. 3A , the immunostaining of stretched smooth muscle cells was mainly localized intracellularly within the cytoplasm and the nucleus. The detected immunohistochemical signal was blocked either when the primary antibody was omitted or when the Cyr61 antigen but not an irrelevant antigen was added to block the primary antibody binding (data not shown). To further investigate the nuclear localization of Cyr61, cells were subjected to mechanical stretch for 1 h, and their nuclei were extracted as previously described (5) . The protein content of nuclear preparations from stretched and unstretched cells was analyzed by Western blotting. As shown in Fig. 3B , a major Cyr61 band was detected in the nuclear extract of stretched cells, confirming the nuclear localization of Cyr61 in the cells.
To determine the signal transduction pathways that couple Cyr61 gene induction to mechanical stimulation, we treated the cells with various pharmacological inhibitors of known signaling cascades before the application of mechanical stretch. Total RNA was extracted and analyzed for Cyr61 mRNA levels. Pretreatment of the cells with either losartan or aminoguanidine, which block angiotensin type I receptor and nitric oxide synthase, respectively, did not affect Cyr61 gene responsiveness to mechanical stretch (data not shown). Representative experiments using inhibitors that consistently affected Cyr61 mRNA levels are shown in Fig. 4A . Either calphostin C, a specific protein kinase C (PKC) inhibitor, or wortmannin, a phosphatidylinositol 3-kinase inhibitor, induced a nearly 45% decrease of Cyr61 mRNA levels in stretched cells but did not completely abrogate the gene expression. The agents bis-indolyl maleimide and quercetin, other specific inhibitors of PKC and phosphatidylinositol 3-kinase, respectively, were equally effective inhibitors of stretch-induced Cyr61 gene expression (data not shown). Additionally, when added to the cells simultaneously, the effects of PKC and phosphatidylinositol 3-kinase inhibitors were not additive, suggesting that PKC and phosphatidylinositol 3-kinase are potentially involved in the same signaling pathway. We further tested the effects the agents GGTI-298 and FTI-277, which inhibit prenylation of some signaling proteins, including those belonging to the small G proteins of the Ras superfamily (27) . Protein prenylation is required for the proper subcellular localization and function of these proteins. Treatment of the cells with GGTI-298 (20 M), a reagent that inhibits protein geranylgeranylation, completely blocked stretched-increased Cyr61 mRNA levels (shown in Fig. 4A ). In contrast, FTI-277 (20 M), a reagent that blocks protein farnesylation, did not affect the expression of Cyr61 gene in stretched cells. These inhibitors were used at concentrations that selectively blocked the prenylation and function of small G proteins like NRas, lamin B, or Rho (24, 27) . This indicates that signaling proteins whose biological activity requires the addition of geranylgeranyl groups play a crucial role in stretch regulation of Cyr61 mRNA levels.
Because the small G proteins of the Rho family such as RhoA are prominent members of the geranylgeranylated protein group, we tested the effects of Y-27632, a specific inhibitor of RhoA-dependent activation of Rho kinase signaling pathways, on Cyr61 gene expression (19) . As shown in Fig. 4B , addition of this agent to the cells dose dependently reduced the levels of Cyr61 mRNA in stretched cells. When Y-27632 was used at a concentration of 0.2 M, the Cyr61 mRNA levels were decreased by 25%. When the concentration used was 20 M, Cyr61 mRNA levels were further reduced by 55% (P Ͻ 0.05). This implicates the RhoA pathways in stretch-induced Cyr61 gene activation.
Previous studies have suggested that RhoA activation regulates gene expression through its effects on the actin cytoskeleton (42) . Therefore, to test whether mechanical stretch regulates Cyr61 gene through actin dynamics, we treated the cells with latrunculin B, a toxin that disrupts actin polymerization by binding and sequestration of G-actin monomers, before the application of mechanical stretch. As shown in Fig. 5A , latrunculin B treatment (0.5 M) of the cells dramatically attenuated (Ϫ45%) stretch-induced Cyr61 mRNA levels (P Ͻ 0.05). Because of its effects on the actin cytoskeleton, treatment of the cells with latrunculin B seemed to alter cell shape momentarily but reversibly (after 8 h), indicating that this drug was not overtly cytotoxic (data not shown). Moreover, to further test whether Cyr61 gene transcription was sensitive to actin dynamics, we treated the cells with jasplakinolide, a toxin known to increase actin polymerization by severing F-actin, creating new nucleation sites that support actin polymerization. As shown in Fig. 5B , jasplakinolide treatment (0.5 M) increased Cyr61 transcription threefold (P Ͻ 0.05). This indicates that Cyr61 gene expression is directly regulated by mechanisms that sense actin dynamics in smooth muscle cells. Additionally, pretreatment of the cells with inhibitors such as calphostin C (50 ng/ml), wortmanin (20 M), or Y-27632 (20 M) did not significantly alter jasplakinolide-induced Cyr61 gene expression (Fig.  5C ). Thus actin polymerization alone is sufficient to induce Cyr61 gene expression and does not require other cooperating signaling molecules such as PKC, phosphatidylinositol 3-kinase, or Rho-associated kinase. Similarly, latrunculin B treatment of the cells did not block jasplakinolide-induced Cyr61 gene expression, consistent with the fact that the two drugs target different types of actin (data not shown).
DISCUSSION
The present study demonstrates that Cyr61 gene expression in cultured bladder smooth muscle cells is inducible by mechanical stretch. Increases of Cyr61 gene expression occurred rapidly after the application of stretch. The message levels were increased five-to ninefold after 30 min and 1 h of mechanical stretching and became undetectable thereafter, reflecting a transient response analogous to that of immediate early genes, i.e., c-fos and egr-1 (11, 29) . The reestablishment of basal levels might be indicative of an adaptive mechanism in which compensatory signaling pathways are activated to allow Cyr61 gene transcription to return to normal levels. The strain magnitude tested (between 2.5 and 7.5%) caused no apparent cell detachment or damage, indicating that stretch-induced Cyr61 gene response was not the result of cell injury. We also showed that while the mRNA levels of Cyr61 gene were increased, those of CTGF, another member of the Cyr61 family, were not affected by mechanical stretch, indicating that stretch-induced Cyr61 mRNA is a selective process. In fact, although Cyr61 and CTGF were shown to behave in a similar manner in that both were simultaneously induced by several serum growth factors, subtle differences exist between them (26). For example, CTGF was shown to be mitogenic by itself, whereas Cyr61 has no intrinsic mitogenic activity but augments growth factor-induced DNA synthesis; Cyr61 was shown to stimulate chemotaxis, whereas CTGF stimulates both chemotaxis and chemokinesis; and, although both Cyr61 and CTGF are extracellular matrix-associated molecules, only CTGF was shown to be secreted in the culture medium. Together, these observations suggest that the expression profile of Cyr61 gene is stimulus specific and might confer phenotypic specificity to the cellular response.
Stretch-induced increases in Cyr61 mRNA levels resulted in increased protein expression that was detected by Western blot in the cell lysates after 1 h and for up to 4 h of mechanical stretching. The persistent increase of the Cyr61 protein in cells, despite an early waning in its mRNA levels, suggests a higher stabilization of the protein in stretched cells. These results corroborate other data indicating that the half-life of the newly synthesized Cyr61 in serum-stimulated 3T3 fibroblasts ranged from 30 min to several hours (20) .
We determined the cellular localization of the protein by immunohistochemical analyses. The immunostaining in stretched cells was mainly localized intracellularly within the cytoplasm and the nucleus. Previous studies have shown that Cyr61 immunoreactivity was detected both intracellularly and extracellularly in smooth muscle of placental tissue (20) . On the basis of structural considerations, the nuclear localization of Cyr61 was surprising, since the primary sequence does not contain a classic nuclear localization signal found in proteins, such as transcription factors, that translocate to the nucleus. In fact, the presence of a peptide signal in the amino-terminal region and the multidomain structure of the protein suggest that the protein is targeted for secretion. Nevertheless, the presence of Cyr61 in the nucleus, while intriguing in its own right, is reminiscent of other examples of proteins found in the nucleus, despite their lack of a nuclear localization signal. The growing list of such polypeptides includes Nov (another member of the Cyr61 family), epidermal growth factors, PDGF, fibroblast growth factors, angiogenin, and parathyroid hormone-related peptide (16, 37) . These proteins are thought to elicit their biological effects in a bifunctional manner: both indirectly through interaction with cell surface receptor linked to conventional signal transduction pathways as well as through direct association with the nuclei of target cells. The biological significance of nuclear targeting of these secretory proteins remains to be determined. In most instances, a number of hypotheses have been put forward regarding transcriptional regulation, translational control, and/or mRNA transport. Thus the detection of Cyr61 in the nuclei of smooth muscle cells opens new prospects as to the biological role of this protein.
In the next step in the analysis of Cyr61 gene activation, we sought to determine the signal transduction pathways required for the response to mechanical stretch. We employed various intracellular inhibitors of known signaling molecules to define the signaling pathways implicated in stretch regulation of Cyr61 gene expression. Inhibitors that interfere with signaling through phospholipase C, cAMP, or mitogen-activated protein kinase (ERK1/2) did not affect the response of Cyr61 gene to stretch (data not shown). Conversely, specific inhibitors of PKC and phosphatidylinositol 3-kinase, used either separately or in combination, partially impaired (ϳ45%) stretch-mediated increased expression of Cyr61 gene. In agreement with our results, O'Brien et al. (34) have shown that activators of PKC such as 12-O-tetradecanoylphorbol 13-acetate induces Cyr61 gene expression while Pendurthi et al. (36) showed that phosphatidylinositol 3-kinase inhibitors completely abrogated the expression Cyr61 gene in response to thrombin or cofactor VIIa stimulation in WI-38 fibroblast. Thus, there are, seemingly, multiple regulatory pathways that may control, possibly independently, the expression of Cyr61 gene. In our model, mechanical stretch signals, in part, through the activation of two signaling pathways (those involving PKC activation and phosphatidylinositol 3-kinase) that could merge and/or overlap downstream.
Additionally, by using specific inhibitors that interfere with protein prenylation, which is required for numerous signaling protein activation and translocation to the plasmic membrane (27, 44) , we found that the mechanical stretch-induced Cyr61 gene was completely suppressed (ϳ96%) by inhibiting the subgroup of proteins that require geranylgeranylation (i.e., Rho family proteins). In contrast, inhibiting the proteins that require farnesylation (such as N-Ras) had no effect. These results indicate that one or more geranylgeranylated proteins is a key player in Cyr61 gene response to mechanical forces and that those of the Rho family of proteins are very likely candidates. Interestingly, numerous studies have shown that Rho proteins were activated in mechanically stretched smooth muscle and shear-stressed endothelial cells (30, 35) . Mechanical stretch of vascular smooth muscle cells induces activation and translocation of RhoA to the membrane at a level comparable to that of known RhoA stimulators such as endothelin, angiotensin II, and lysophosphatidic acid (33) . Several putative stretch-sensing structures mediate Rho activation, including growth factor receptors (i.e., receptor tyrosine kinases), G protein-coupled receptors, and integrins (22, 29) . These membrane receptors may either independently or coordinately regulate the activity of Rho. The data presented in Fig. 4B indicate that the selective inhibition of RhoA and its associated kinase p160 ROCK using the Y-27632 inhibitor significantly reduced the mRNA levels of Cyr61 (P Ͻ 0.05). This suggests that mechanical stretch signals to Cyr61 gene expression through Rho-dependent activation of Rhoassociated kinase.
It is well known that RhoA-dependent activation of Rho kinase induces actin polymerization and stress fiber formation in many cell types, including smooth muscle cells (1, 44) . Rho-associated kinase phosphorylates and inactivates the myosin-binding subunit of myosin light chain phosphatase, thereby inhibiting myosin light chain dephosphorylation. As a result, the phosphorylated form of myosin light chain accumulates, leading to contraction of the actomyosin-based cytoskeleton of smooth muscle. Our data indicated that drug-induced modulation of the actin cytoskeleton affected Cyr61 gene expression. Treatment of the cells with the drug latrunculin B, which inhibits actin polymerization, markedly impaired stretch-induced Cyr61 gene transcription. This supports a model in which RhoA-mediated increase in actin polymerization promotes specific gene expression. Previous studies have shown that several immediate early genes, including c-fos and smooth muscle cell-specific genes, were activated through RhoA proteins and were sensitive to actin dynamics (35, 42) . A plausible explanation to such a regulation suggests a model whereby, in the absence of Rho-induced actin polymerization, G-actin inhibits transcription factors such as serum-response factor (SRF) or nuclear factor (NF)-B, either directly or by sequestering cofactors required for their activation (31, 46) . Activation of such trans-acting factors and their translocation to the nucleus is required for the activation of their targeted genes. In agreement with this, the Cyr61 gene promoter contains several trans-acting factor-binding sites including those for SRF, AP-1, and NF-B (25) . Whether stretch activation of Cyr61 gene requires activation of such trans-acting factors remains to be elucidated. Future work will be directed toward defining the transcriptional and/or posttranscriptional requirements for stretch-induced Cyr61 gene expression and understanding the role of actin dynamics in such activation.
Overall, our study demonstrates that induction of Cyr61 gene expression is not under the control of serum growth factors only, as shown in previous reports, but is also regulated by mechanical stimuli, thus extending the biological context of Cyr61 gene activation. Induced Cyr61 gene response to stretch is not unique to cells from the bladder tissue but is also shared by lamina propria fibroblasts and smooth muscle cells from other tissues such as the aorta (data not shown). However, only a modest 2-to 2.5-fold increase of Cyr61 mRNA levels was observed in these cells compared with a 5-to 9-fold increase in bladder smooth muscle cells when subjected to the same stretch regimen. Whether these differences represent intrinsic properties of bladder smooth muscle cells and what the biological significance of this may be will require further investigation. Nevertheless, the utilization of various pharmacological inhibitors disclosed a net effect of signaling through PKC, phosphatidylinositol 3-kinase, and Rho-associated kinase in stretch-induced Cyr61 gene expression. The different degree of inhibition observed by a given inhibitor may reflect either the difference of the contribution of each signaling molecule to the gene expression or a potential complex and interdependent signaling networks involved. Indeed, a key component of the downstream pathway of either PKC or phosphatidylinositol 3-kinase is the actin cytoskeleton (17, 22, 43) . The importance of the latter in relaying PKC and phosphatidylinositol 3-kinase signals has been reported and may play a role in mediating Cyr61 gene activation. Studies have shown that direct activation of PKC isoforms by phorbol ester has dramatic effects on the assembly and disassembly of the F-actin network, and there is abundant evidence showing an isoenzyme-specific translocation to the Factin components of the cytoskeleton in intact cells (18, 41) . Alternatively, either PKC or phosphatidylinositol 3-kinase may affect reorganization of the actin cytoskeleton and gene expression through their interaction with Rho proteins, although activation of PKC and/or phosphatidylinositol 3-kinase can be either upstream or downstream of the Rho family, depending on the system (39, 45) . The precise complex mechanism underlying cross talk between these signaling molecules and the actin cytoskeleton and its impact on stretch-induced Cyr61 gene expression is yet to be determined. On the other hand, the ability of jasplakinolide-mediated actin polymerization to induce, on its own, Cyr61 gene expression supports a model in which selective and specific gene expression is controlled by changes in G-and F-actin levels in the cells. Such a regulatory mechanism has been demonstrated for a subset of SRF target genes such as SRF itself and vinculin (42) .
Finally, the upregulation of Cyr61 gene expression by mechanical strain may have pathophysiologically relevant implications in vivo. Several pathological conditions that result from increased mechanical strain such as hypertension, bladder outlet obstruction, atherosclerosis, and acute respiratory distress syndrome, are characterized by hypertrophy/hyperplasia, fibrosis, and/or modulation phenotypic of smooth muscle cells (6, 15, 42) . Therefore, on the basis of currently known biological activities of the Cyr61 recombinant protein, we anticipate that increased Cyr61 protein levels in highly stressed tissues likely play a major role as an early marker and a potent effector of the remodeling process in smooth muscle compartments (14, 26) . Cyr61 may participate in such a process by stimulat-ing, in either a direct or indirect fashion, cell migration, attachment, and/or proliferation. Moreover, both the Cyr61 gene expression pattern and its regulatory mechanism (as demonstrated by its gene responsiveness to either actin dynamics or RhoA signaling, a critical mechanism for regulation of smooth muscle cell differentiation) seem to be similar to those of prohypertrophic molecules, i.e., SRF and ␣-actin (31, 42) . Therefore, Cyr61 is a potential early molecular signal of smooth muscle cell differentiation and may be involved in the activation of specific features of their hypertrophic response in pathological conditions. Accordingly, a detailed study of the functional significance of Cyr61 gene activation in stress-related pathologies is warranted.
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